Accenture ranked #10 Holder of Pervasive Neurotech Intellectual Property*

by

accentureAccen­ture is a multi­na­tion­al firm pro­vid­ing con­sult­ing, tech­nol­o­gy, and out­sourc­ing ser­vices to enter­prise clients. As human cap­i­tal is the pri­ma­ry val­ue dri­ver for Accen­ture’s ser­vices, Accen­ture has devised large num­ber of process­es for train­ing and enhanc­ing the abil­i­ties of its employees.

  • Stock Tick­er: NYSE:ACN
  • Num­ber of employ­ees: 10,000+
  • Per­va­sive neu­rotech US patent grants: 50
  • Per­va­sive neu­rotech US pend­ing appli­ca­tions: 4

*Accen­ture ranked #10 in Sharp­Brains’ Per­va­sive Neu­rotech IP Strength Index, thanks to patents such as:

  • US6611822: Sys­tem method and arti­cle of man­u­fac­ture for cre­at­ing col­lab­o­ra­tive appli­ca­tion sharing
  • US6064998: Sys­tem, method and arti­cle of man­u­fac­ture for a sim­u­la­tion engine with an expert sys­tem exam­ple pro­cess­ing engine
  • US6993513: Inter­ac­tive sim­u­la­tions uti­liz­ing a remote knowl­edge base

To learn more about Sharp­Brains’ take on the orga­ni­za­tion’s #Per­va­siveNeu­rotech IP port­fo­lio, and over­all data and trends, click on Per­va­sive Neu­rotech­nol­o­gy: A Ground­break­ing Analy­sis of 10,000+ Patent Fil­ings Trans­form­ing Med­i­cine, Health, Enter­tain­ment, and Busi­ness.